DMPA-SC Self-injection Contraceptive Continuation Research Brief
Subcutaneous DMPA (DMPA-SC, brand name Sayana® Press) is a new, easy-to-use injectable contraceptive that is ideally suited for remote access and even self-injection. This research brief describes new research findings that women who self-injection DMPA-SC continue to use contraception longer than women who use intramuscular DMPA (DMPA-IM, brand name Depo-Provera®) administered by a health worker. For more information, visit www.path.org/dmpa-sc or email FPoptions@path.org.
Publication date: July 2018
Available materials
-
English
-
French
-
Portuguese